A pharmacogenetics-based warfarin maintenance dosing algorithm from Northern Chinese patients.

A pharmacogenetics-based warfarin maintenance dosing algorithm from Northern Chinese patients.

Inconsistent associations with warfarin dose were observed in genetic variants except VKORC1 haplotype and CYP2C9*3 in Chinese people, and few studies on warfarin dose algorithm was performed in a large Chinese Han population lived in Northern China. Of 787 consenting patients with heart-valve repla...

Full description

Bibliographic Details
Main Authors:	Jinxing Chen, Liying Shao, Ling Gong, Fang Luo, Jin'e Wang, Yi Shi, Yu Tan, Qianlong Chen, Yu Zhang, Rutai Hui, Yibo Wang
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2014-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4134280?pdf=render

Similar Items

Pharmacogenetic Warfarin Dosing Algorithm in the Russian Population
by: T. A. Bairova, et al.
Published: (2019-07-01)

Warfarin dosage response related pharmacogenetics in Chinese population.
by: Siyue Li, et al.
Published: (2015-01-01)

Comparison of Nine Statistical Model Based Warfarin Pharmacogenetic Dosing Algorithms Using the Racially Diverse International Warfarin Pharmacogenetic Consortium Cohort Database.
by: Rong Liu, et al.
Published: (2015-01-01)

Verification of pharmacogenetics-based warfarin dosing algorithms in Han-Chinese patients undertaking mechanic heart valve replacement.
by: Li Zhao, et al.
Published: (2014-01-01)

Warfarin anticoagulant therapy: a Southern Italy pharmacogenetics-based dosing model.
by: Cristina Mazzaccara, et al.
Published: (2013-01-01)

Pharmacogenetics of VKORC1 in warfarin resistant patients.
by: Ong, Jacqueline Kai Mei.
Published: (2010)

Warfarin Pharmacogenetics: Challenges and Opportunities for Clinical Translation
by: Nita A Limdi, et al.
Published: (2012-10-01)

Machine Learning Algorithm for Predicting Warfarin Dose in Caribbean Hispanics Using Pharmacogenetic Data
by: Abiel Roche-Lima, et al.
Published: (2020-01-01)

A Novel Admixture-Based Pharmacogenetic Approach to Refine Warfarin Dosing in Caribbean Hispanics.
by: Jorge Duconge, et al.
Published: (2016-01-01)

A Randomized Trial of Pharmacogenetic Warfarin Dosing in Naïve Patients with Non-Valvular Atrial Fibrillation.
by: Vittorio Pengo, et al.
Published: (2015-01-01)

Potential of a Pharmacogenetic-Guided Algorithm to Predict Optimal Warfarin Dosing in a High-Risk Hispanic Patient
by: Dagmar F. Hernandez-Suarez MD, et al.
Published: (2016-12-01)

Warfarin maintenance dose prediction for Chinese after heart valve replacement by a feedforward neural network with equal stratified sampling
by: Weijie Ma, et al.
Published: (2021-07-01)

Warfarin therapy and pharmacogenetics: A narrative review of regional and Iraqi studies
by: Ali Mohammed Abd Alridha, et al.
Published: (2022-01-01)

A review of a priori regression models for warfarin maintenance dose prediction.
by: Ben Francis, et al.
Published: (2014-01-01)

Using Pharmacogenetic Testing to Tailor Warfarin Therapy: The Singapore Experience and What the Future Holds
by: Grace Shu-wen Chang, et al.
Published: (2020-06-01)

Therapeutic Drug Monitoring and Pharmacogenetic Testing in Northern China
by: Chunyan Zhang, et al.
Published: (2021-11-01)

VKORC1 pharmacogenetics and pharmacoproteomics in patients on warfarin anticoagulant therapy: transthyretin precursor as a potential biomarker.
by: Ramasamy Saminathan, et al.
Published: (2010-12-01)

Frequency of two VKORC1 gene variants and its correlation with warfarin maintenance dose
by: esmat khaleqsefat, et al.
Published: (2018-12-01)

Thrombotic genetic risk factors and warfarin pharmacogenetic variants in São Miguel's healthy population (Azores)
by: Pacheco Paula R, et al.
Published: (2009-06-01)

The Active Metabolite of Warfarin (3'-Hydroxywarfarin) and Correlation with INR, Warfarin and Drug Weekly Dosage in Patients under Oral Anticoagulant Therapy: A Pharmacogenetics Study.
by: Donato Gemmati, et al.
Published: (2016-01-01)

Modern warfarin- dosing algorithms in patients with atrial fibrillation
by: M. Yu. Kolesnyk, et al.
Published: (2015-12-01)

To assess the prevalence of genetic variation in warfarin metabolism and its effects on maintenance dose in patients requiring oral anticoagulation
by: Pankaj Batra, et al.
Published: (2014-11-01)

Impact of pharmacogenetic testing on the risk of bleedings and excessive hypocoagulation episodes in the use of warfarin: The first meta-analysis of Russian prospective studies
by: D A Sychev, et al.
Published: (2014-04-01)

Comparison of warfarin dosage fluctuation with time in therapeutic range for bleeding or thromboembolism rate in Chinese patients
by: Hsi-Yu Yu, et al.
Published: (2019-02-01)

Improved stacking ensemble learning based on feature selection to accurately predict warfarin dose
by: Mingyuan Wang, et al.
Published: (2024-01-01)

Optimal loading dose of warfarin for the initiation of oral anticoagulation.
by: Mahtani, K, et al.
Published: (2012)

Pharmacogenetic association of the NR1H3 promoter variant with antihypertensive response among patients with hypertension: A longitudinal study
by: Yu Chen, et al.
Published: (2023-03-01)

Knowledge of warfarin therapy among patients attending Warfarin Clinic at a Public Hospital in Northern part of Malaysian Peninsular
by: Teoh Boon Ching, et al.
Published: (2016-01-01)

Interaction Between Chinese Medicine and Warfarin: Clinical and Research Update
by: Wei Zhuang, et al.
Published: (2021-09-01)

Genetic factors associated with patient-specific warfarin dose in ethnic Indonesians
by: Utama Andi, et al.
Published: (2011-06-01)

Application of a warfarin dosing calculator to guide individualized dosing versus empirical adjustment after fixed dosing: a pilot study
by: Xiaofang Cai, et al.
Published: (2023-08-01)

Safety and efficacy of low-dose non-vitamin K antagonist oral anticoagulants versus warfarin after left atrial appendage closure with the Watchman device
by: Guohua Fu, et al.
Published: (2022-08-01)

Effects of coagulation factor VII polymorphisms on warfarin sensitivity and responsiveness in Jordanian cardiovascular patients during the initiation and maintenance phases of warfarin therapy
by: AL-Eitan LN, et al.
Published: (2019-01-01)

Pharmacogenetics Based Dose Prediction Model for Initial Tacrolimus Dosing in Renal Transplant Recipients
by: Lekshmy Srinivas, et al.
Published: (2021-11-01)

Platelet and coagulation hemostasis status in patients with atrial fibrillation depending on warfarin dosing method
by: M. Yu. Kolesnyk, et al.
Published: (2022-12-01)

Impact of VKORC1, CYP4F2 and NQO1 gene variants on warfarin dose requirement in Han Chinese patients with catheter ablation for atrial fibrillation
by: Jiao Li, et al.
Published: (2018-05-01)

Pharmacogenetics of Anticoagulation and Clinical Events in Warfarin-Treated Patients: A Register-Based Cohort Study with Biobank Data and National Health Registries in Finland
by: Vuorinen AL, et al.
Published: (2021-03-01)

Optimal loading dose for the initiation of warfarin: a systematic review
by: Heneghan, C, et al.
Published: (2010)

Adjustments to warfarin dosing after gastric bypass and sleeve gastrectomy
by: Nor Hanipah, Zubaidah, et al.
Published: (2018)

Warfarin: do we need genotype-based dose prediction?
by: Yenny Yenny
Published: (2016-02-01)